Label-free viability determination and cell sizing.
Here we take a look at some of the most famous scientific predictions that were shown to be a little wide of the mark.
John Brennan, Professor and Director, Biointerfaces Institute, McMaster University tells us about some of the challenges of developing paper based diagnostic devices.
Another “first” for Chinese researchers highlights how the race to develop CRISPR based therapeutics is heating up.
Biosensors containing up to 100 stacked layers of antibodies offer greater sensitivity.
New resource will greatly accelerate scientific discovery and the rate of wheat improvement.
Researchers provide evidence that mild traumatic brain injury is associated with greater neurodegeneration and reduced memory performance in people genetically at risk of Alzheimer's Disease.
ARIAD Pharmaceuticals today announced it has entered into a definitive agreement to be acquired by Takeda Pharmaceutical Company.
Jan 18 - Jan 19, 2017